APRIL MILLER: Open Payments
NPI 1548621220 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 22 payments from 9 companies in 2025. Trend: 2023 $819 · 2024 $221 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $154 |
| GlaxoSmithKline, LLC. | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $29 |
| Dexcom, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
Products named: DALVANCE, SHINGRIX, Kerendia, GEMTESA, UBRELVY, Dexcom G6 Transmitter, TEFLARO, PREVNAR 20.
Industry payments across AL — which companies pay providers there.
